As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’
The trick is in asking who owns the patent. I suspect you’re going to see a bunch of Chinese/Indian generics that cost pennies on the US dollar, because they see an economic benefit in people not having HIV that Americans can’t grasp.
The trick is in asking who owns the patent. I suspect you’re going to see a bunch of Chinese/Indian generics that cost pennies on the US dollar, because they see an economic benefit in people not having HIV that Americans can’t grasp.
American corporations can grasp the benefit. They just don’t care.